Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati (Q47587104)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Bordetella pertussis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daniel Rabczenko

4

object named as

Daniel Rabczenko

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Janusz Slusarczyk

6

object named as

Janusz Slusarczyk

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

author name string

Anna Gzyl

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Ewa Augustynowicz

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Grzegorz Gniadek

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Grazyna Dulny

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

22

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

17-18

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

2122-2128

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Masseteric silent period in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Pertussis in Poland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Impact of anti-vaccine movements on pertussis control: the untold story

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Global DTP manufacturing capacity and capability. Status report: January 1995.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.12.006

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15149768

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47587104&oldid=2124765821"